Sinopharm

Omicron-specific Sinopharm COVID vaccine candidates cleared for clinical trial

BEIJING, April 16 (Reuters) - Two COVID-19 vaccine candidates developed by units of China National Biotec Group (CNBG) to target the Omicron variant were approved for clinical trials as boosters in Hong…

Read More Here

Sinopharm protein-based booster stronger against Omicron than earlier shot -study

BEIJING, Jan 7 (Reuters) - A protein-based COVID-19 vaccine made by Sinopharm, when given as a booster after two doses of an earlier shot from the Chinese firm, elicited a…

Read More Here

Sinopharm’s COVID booster reverses antibody decline, enhances cell-based responses – study

A third shot of Sinopharm's COVID-19 vaccine leads to a rebound in antibody levels that drop months after a second dose, a small-scale Chinese study showed. It also showed the…

Read More Here

WHO begins shipping Chinese vaccines despite some misgivings

The World Health Organization’s pandemic programme plans to ship 100 million doses of the Sinovac and Sinopharm COVID-19 shots by the end of next month, mostly to Africa and Asia,…

Read More Here

Peru study finds Sinopharm COVID vaccine 50.4% effective against infections

A two-dose COVID-19 vaccine from China's Sinopharm was 50.4% effective in preventing infections in health workers in Peru when it was seeing a surge in cases fuelled by virus variants,…

Read More Here

Sinopharm’s COVID-19 shot offers weaker protection among elderly – study

Sinopharm's COVID-19 vaccine was less effective in offering protection against the disease among the elderly, according to the results of a Hungarian study. The study of 450 participants who had…

Read More Here

Abu Dhabi begins trial of Sinopharm vaccine on children aged 3-17

Abu Dhabi is beginning a trial administering China’s Sinopharm vaccine to children aged 3-17. The trial will monitor the immune response of 900 children “in preparation to vaccinate children in…

Read More Here

Sinopharm’s two COVID-19 shots effective, study says

Two COVID-19 vaccines from China's Sinopharm showed more than 70% efficacy against symptomatic cases, but it remains unclear how much protection they provide against severe or asymptomatic cases, according to…

Read More Here

GAVI in talks with China’s Sinopharm, other vaccine makers for COVAX doses

The GAVI Vaccine Alliance is in talks with COVID-19 vaccine manufacturers including China's state-owned Sinopharm to expand the COVAX pipeline and secure doses for distribution, a GAVI spokeswoman said on…

Read More Here

Sinopharm’s protein-based COVID-19 vaccine candidate gets China clinical trial nod

The China National Biotec Group Company (CNBG) has obtained regulatory approval to move a third COVID-19 vaccine candidate into the human testing stage in China, CNBG said on Saturday. The…

Read More Here

Serbia plans to start manufacturing Sinopharm, Sputnik shots

Serbia announced it plans to start domestic production of Russia’s Sputnik V vaccine in May and China’s Sinopharm shot by mid-October. After meeting United Arab Emirates Crown Prince Mohammed bin…

Read More Here

Hungary’s PM Orban receives Chinese vaccine as govt ramps up rollout

BUDAPEST, Feb 28 (Reuters) - Hungarian Prime Minister Viktor Orban has been vaccinated with a coronavirus vaccine developed by China's Sinopharm, Orban announced on his official Facebook page on Sunday…

Read More Here

Over 43 million doses of Sinopharm’s COVID-19 vaccines used globally

More than 43 million COVID-19 vaccine doses from China's state-backed China National Pharmaceutical Group (Sinopharm) have been used, including over 34 million administered in the country and the rest overseas,…

Read More Here